Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Drug Distribution: Physiological Barriers01:23

Factors Affecting Drug Distribution: Physiological Barriers

743
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
743
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

488
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
488
Factors Affecting Drug Distribution: Miscellaneous Factors01:19

Factors Affecting Drug Distribution: Miscellaneous Factors

1.0K
Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
1.0K
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

332
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
332
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

575
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
575
Factors Influencing Drug Absorption: Drug Dissolution01:27

Factors Influencing Drug Absorption: Drug Dissolution

1.2K
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of VetCompass Australia data to estimate body weight for antimicrobial stewardship in Australian dogs.

Australian veterinary journal·2026
Same author

Effects of Social Status on Reproductive Success, Physiology and Maternal Care in Socially housed Female Rhesus Macaques.

bioRxiv : the preprint server for biology·2025
Same author

Barium ion sensing with IPG K<sup>+</sup> molecular probes.

The Analyst·2025
Same author

The effects of chronic social stress on cognitive flexibility in adult female macaques.

bioRxiv : the preprint server for biology·2025
Same author

Structural Effects of Low Social Status and Obesogenic Diet on Social and Emotional Neurocircuits in Female Macaques: A Longitudinal Study from Infancy to Adulthood.

bioRxiv : the preprint server for biology·2025
Same author

Demonstration of event position reconstruction based on diffusion in the NEXT-white detector.

The European physical journal. C, Particles and fields·2024
Same journal

The NTP Chronic Inhalation Study Does Not Support an Inherent Lung Cancer Hazard of Talc: Implications of Lung Particle Overload and Maximum Tolerated Dose.

Regulatory toxicology and pharmacology : RTP·2026
Same journal

Consideration of Carcinogenicity and Mode of Action Information by an Independent Expert Panel to Support Derivation of No-Significant-Risk-Level Values for Vinyl Acetate Monomer.

Regulatory toxicology and pharmacology : RTP·2026
Same journal

Which carcinogenicity study should I use? Automated identification of reliable studies.

Regulatory toxicology and pharmacology : RTP·2026
Same journal

Adoption of artificial intelligence in drug review across the lifecycle: Transformation of regulatory decision-making.

Regulatory toxicology and pharmacology : RTP·2026
Same journal

Cardiovascular outcomes following intrauterine and lactational exposure to cyantraniliprole in male Wistar rats.

Regulatory toxicology and pharmacology : RTP·2026
Same journal

Pesticide residue and mycotoxin occurrence in apples and their impact on human health in Morocco.

Regulatory toxicology and pharmacology : RTP·2026
See all related articles

Related Experiment Video

Updated: Feb 10, 2026

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

5.4K

Physiological factors affecting drug toxicity.

K Bailey

    Regulatory Toxicology and Pharmacology : RTP
    |December 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Drug absorption, distribution, metabolism, and excretion (ADME) are influenced by physiological factors like age, genetics, and disease. Understanding these variations is crucial for safe and effective drug therapy, minimizing toxicity risks.

    More Related Videos

    Measuring RAN Peptide Toxicity in C. elegans
    10:49

    Measuring RAN Peptide Toxicity in C. elegans

    Published on: April 30, 2020

    7.1K
    Assaying &#946;-amyloid Toxicity using a Transgenic C. elegans Model
    13:59

    Assaying β-amyloid Toxicity using a Transgenic C. elegans Model

    Published on: October 9, 2010

    26.7K

    Related Experiment Videos

    Last Updated: Feb 10, 2026

    Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
    11:06

    Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

    Published on: January 31, 2022

    5.4K
    Measuring RAN Peptide Toxicity in C. elegans
    10:49

    Measuring RAN Peptide Toxicity in C. elegans

    Published on: April 30, 2020

    7.1K
    Assaying &#946;-amyloid Toxicity using a Transgenic C. elegans Model
    13:59

    Assaying β-amyloid Toxicity using a Transgenic C. elegans Model

    Published on: October 9, 2010

    26.7K

    Area of Science:

    • Pharmacology and Toxicology
    • Drug Metabolism and Pharmacokinetics (DMPK)

    Background:

    • Physiological factors significantly impact how the body processes drugs (ADME).
    • Key influences include disease, genetics, age, nutrition, sex, hormonal status, and circadian rhythms.
    • These factors can alter drug pharmacology and toxicology, affecting patient outcomes.

    Purpose of the Study:

    • To review physiological factors influencing drug disposition and toxicity.
    • To highlight the importance of individual variations in drug response.
    • To underscore the need for personalized drug administration strategies.

    Main Methods:

    • Literature review of physiological factors affecting drug ADME.
    • Analysis of studies on disease, genetics, age, and other influences.
    • Illustration of effects with examples from scientific literature.

    Main Results:

    • Diseases often reduce drug absorption and excretion, particularly in the elderly with impaired renal function.
    • Body composition (e.g., fat proportion) affects drug distribution.
    • Circadian rhythms, genetics (polymorphisms in metabolizing enzymes), and environmental factors modify drug metabolism and disposition.
    • Drug toxicity can be exacerbated by specific disease states or inappropriate timing of administration.

    Conclusions:

    • Individual physiological variations necessitate tailored approaches to drug therapy.
    • Understanding these factors is critical for optimizing therapeutic efficacy and preventing adverse drug events.
    • Further research into genetic and environmental influences on drug disposition is essential.